Emily Gottschalk's most recent trade in Anixa Biosciences Inc was a trade of 25,000 Employee Stock Option done . Disclosure was reported to the exchange on Jan. 5, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Anixa Biosciences Inc | Emily Gottschalk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 25,000 | 25,000 | - | - | Employee Stock Option | |
| Anixa Biosciences Inc | Emily Gottschalk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 25,000 | 25,000 | - | - | Employee Stock Option | |
| Anixa Biosciences Inc | Emily Gottschalk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 25,000 | 25,000 | - | - | Employee Stock Option (Right to Buy) | |
| Anixa Biosciences Inc | Emily Gottschalk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 25,000 | 25,000 | - | - | Employee Stock Option (Right to Buy) | |
| Anixa Biosciences Inc | Emily Gottschalk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 100,000 | 100,000 | - | - | Employee Stock Option (Right to Buy) |